Drug Profile


Alternative Names: AI-700; Imagify; Long retention time synthetic microspheres; Perflubutane Polymer Microspheres

Latest Information Update: 24 Apr 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Massachusetts Institute of Technology
  • Developer Acusphere
  • Class Contrast media; Fluorocarbons; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Coronary disorders

Highest Development Phases

  • No development reported Coronary disorders

Most Recent Events

  • 28 Aug 2014 Development is ongoing in USA
  • 24 Jul 2014 Regulatory submission withdrawn for Coronary disorders (Diagnosis) in European Union (IV)
  • 24 Oct 2012 Preregistration for Coronary disorders (diagnosis) in European Union (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top